Liver Transplant

What Is a Liver Transplant?

A liver transplant is a surgical procedure that replaces a diseased or failing liver with a healthy liver from a donor. The new liver can be a whole organ or a partial segment, and it may come from a deceased donor or, in some cases, a living donor.

Why Is the Liver Important?

The liver performs more than 500 vital functions, including detoxification of blood, production of bile for digestion, synthesis of clotting factors, storage of glycogen, and regulation of cholesterol. When the organ can no longer perform these tasks, a transplant may become necessary.

Common Indications for Transplant

• Cirrhosis advanced scarring from chronic hepatitis B or C, alcoholrelated liver disease, or nonalcoholic steatohepatitis (NASH).
• Acute liver failure rapid loss of liver function due to drug toxicity, viral hepatitis, or autoimmune disease.
• Primary biliary cholangitis and primary sclerosing cholangitis progressive diseases that destroy bile ducts.
• Metabolic disorders such as Wilsons disease or certain glycogen storage diseases.

The Transplant Process

1. Evaluation

Potential recipients undergo a comprehensive assessment, including blood tests, imaging, cardiac evaluation, and psychosocial screening. The goal is to ensure the patient can survive surgery and adhere to postoperative care.

2. Listing and Allocation

Qualified candidates are placed on a national waiting list. Allocation is guided by the MELD (Model for EndStage Liver Disease) score, which predicts shortterm mortality based on laboratory values. Higher MELD scores receive priority.

3. Donor Types

• Deceased donor liver recovered after brain death or circulatory death.
• Living donor a healthy individual donates a portion (typically the right lobe) of their liver. The donors liver regenerates, as does the transplanted segment.

4. Surgery

The operation lasts 412 hours. The diseased liver is removed, and the donor liver is implanted, connecting the hepatic veins, portal vein, hepatic artery, and bile duct. In livingdonor transplants, surgeons remove a portion of the donors liver, which then grows to full size within weeks.

5. Immediate PostOperative Care

Patients stay in the intensive care unit for 13 days, followed by a regular transplant ward. Immunosuppressive drugs are started to prevent rejection, and blood work is performed frequently to monitor liver function.

Risks and Complications

• Bleeding or infection
• Rejection of the graft
• Biliary complications (leaks or strictures)
• Renal dysfunction
• Recurrence of the original disease

While complications can be serious, modern surgical techniques and improved immunosuppression have lowered mortality to under 10% at one year in many centers.

Immunosuppression

Longterm medication is essential. The most common regimen includes a calcineurin inhibitor (tacrolimus or cyclosporine), an antiproliferative agent (mycophenolate mofetil), and steroids (usually tapered off within six months). Patients must adhere strictly to dosing schedules and routine blood monitoring.

LivingDonor Liver Transplant (LDLT)

LDLT offers several advantages: reduced waiting time, better graft quality, and the possibility of scheduling the operation. However, it carries a risk to the donor, such as postoperative pain, bile leaks, or rare liver failure. Careful donor evaluation and counseling are crucial.

Life After Transplant

Most recipients enjoy a marked improvement in quality of life, gaining back energy, appetite, and normal lab values. Ongoing care includes:

• Regular followup visits (initially every few weeks, then every 36 months).
• Monitoring for rejection, infection, and malignancy.
• Adherence to a balanced diet low in sodium and rich in protein.
• Avoidance of alcohol and hepatotoxic drugs.
• Vaccinations for hepatitis A, B, influenza, and other preventable diseases.

Survival Statistics

According to recent registry data, patient survival rates are approximately:

• 90% at 1 year
• 80% at 5 years
• 70% at 10 years

Graft survival follows a similar pattern, with slightly lower percentages due to occasional graft loss.

Future Directions

Research is focusing on:

• Machine perfusion keeping donor livers viable longer and improving marginal organ use.
• Tolerance induction reducing or eliminating the need for lifelong immunosuppression.
• Stemcell based therapies regenerating damaged liver tissue without transplantation.
• Genetic editing correcting inherited metabolic disorders before transplantation.

How to Get Help

If you or a loved one may need a liver transplant, start by contacting a transplant center or a hepatology specialist. They can guide you through evaluation, listing, and potential donor matching. Support groups, both inperson and online, also provide emotional assistance and practical advice.

Key Takeaways

• Liver transplantation is a lifesaving procedure for endstage liver disease.
• Evaluation, MELD scoring, and donor availability determine transplant timing.
• Both deceaseddonor and livingdonor transplants are performed; each has unique benefits and risks.
• Longterm success depends on strict medication adherence, regular monitoring, and a healthy lifestyle.
• Advances in technology and immunology continue to improve outcomes and expand eligibility.

For further reading, reputable sources include the United Network for Organ Sharing (UNOS), the American Liver Foundation, and peerreviewed journals such as Liver Transplantation.